Medpace
MEDP
586 hedge funds and large institutions have $7.77B invested in Medpace in 2025 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 232 increasing their positions, 212 reducing their positions, and 72 closing their positions.
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
2.36% more ownership
Funds ownership: 81.42% → 83.78% (+2.4%)
9% more repeat investments, than reductions
Existing positions increased: 232 | Existing positions reduced: 212
0% less capital inflows, than outflows
Capital inflows: $866M | Capital outflows: $868M
1% less funds holding
Funds holding: 592 → 586 (-6)
13% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 72
34% less call options, than puts
Call options by funds: $14.5M | Put options by funds: $22M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$234M |
| 2 |
Vulcan Value Partners
Birmingham,
Alabama
|
+$75.5M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$35.6M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$34.3M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$30.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$146M |
| 2 |
Goldman Sachs
New York
|
-$53.5M |
| 3 |
Camber Capital Management
Boston,
Massachusetts
|
-$41.5M |
| 4 |
KCM
Kensico Capital Management
Greenwich,
Connecticut
|
-$40.2M |
| 5 |
Wasatch Advisors
Salt Lake City,
Utah
|
-$36.1M |
MEDP Hedge Fund Activity: Q1 2025 in Review
586 of the 7,490 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2025, worth a combined $7.77B — down 7.6% from $8.41B a quarter earlier.
Sellers outnumbered buyers: 72 funds closed out of MEDP and 63 opened new positions — a net loss of 9 holders — while 212 trimmed existing stakes and 232 added.
The largest buyer was Mawer Investment Management, opening a new position worth an estimated $234M. The largest seller was Capital World Investors, cutting an estimated $146M.
- 586 institutional investors held Medpace (MEDP) as of Q1 2025, down from 592 in Q4 2024.
- Funds reported $7.77B of Medpace stock for Q1 2025, down 7.6% quarter-over-quarter.
- 63 funds opened new Medpace positions in Q1 2025 and 72 closed out, a net change of -9 holders.
- The largest Medpace buyer in Q1 2025 was Mawer Investment Management, an estimated $234M added.
- The largest Medpace seller in Q1 2025 was Capital World Investors, an estimated $146M sold.
Based on aggregated 13F filings for Q1 2025.